Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Is Boston Scientific Bsx Priced Right A Comprehensive Guide To Its Market Value | RobinsPost News & Noticias

UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings


Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23, UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) ... Read More

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet


When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ... Read More

Leerink Partners Maintains Boston Scientific (BSX) Outperform Recommendation


Fintel reports that on October 1, 2025, Leerink Partners maintained coverage of Boston Scientific (NYSE:BSX) with a Outperform recommendation. As of September 30, 2025, the average one-year price ... Read More

If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today


Boston Scientific (NYSE: BSX) has outperformed the market over the past 15 years by 7.91% on an annualized basis producing an average annual return of 20.24%. Currently, Boston Scientific has a market ... Read More

Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost


Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More

Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?


Boston Scientific Corp. (NYSE: BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More

Boston Scientific lifts annual profit forecast on strong demand for heart devices


Oct 22 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong demand for its heart devices, sending ... Read More

What the Options Market Tells Us About Boston Scientific


Deep-pocketed investors have adopted a bullish approach towards Boston Scientific (NYSE:BSX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ... Read More

Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics


Wall Street analysts forecast that Boston Scientific (BSX) will report quarterly earnings of $0.71 per share in its upcoming release, pointing to a year-over-year increase of 12.7%. It is anticipated ... Read More

Boston Scientific boosts chronic pain therapy portfolio with Nalu deal


Oct 17 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus